These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


358 related items for PubMed ID: 9754559

  • 21. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
    Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen O.
    Cell Immunol; 1997 Oct 10; 181(1):93-100. PubMed ID: 9344501
    [Abstract] [Full Text] [Related]

  • 22. Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively.
    Tóth R, Szegezdi E, Molnár G, Lord JM, Fésüs L, Szondy Z.
    Eur J Immunol; 1999 Feb 10; 29(2):383-93. PubMed ID: 10064053
    [Abstract] [Full Text] [Related]

  • 23. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M, Weller M.
    Cell Death Differ; 2003 Sep 10; 10(9):1078-89. PubMed ID: 12934082
    [Abstract] [Full Text] [Related]

  • 24. CD99 signals caspase-independent T cell death.
    Pettersen RD, Bernard G, Olafsen MK, Pourtein M, Lie SO.
    J Immunol; 2001 Apr 15; 166(8):4931-42. PubMed ID: 11290771
    [Abstract] [Full Text] [Related]

  • 25. Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism.
    Greeneltch KM, Kelly-Welch AE, Shi Y, Keegan AD.
    J Immunol; 2005 Oct 15; 175(8):4999-5005. PubMed ID: 16210602
    [Abstract] [Full Text] [Related]

  • 26. THP-1 monocytic leukemia cells express Fas ligand constitutively and kill Fas-positive Jurkat cells.
    Bremner TA, Chatterjee D, Han Z, Tsan MF, Wyche JH.
    Leuk Res; 1999 Oct 15; 23(10):865-70. PubMed ID: 10573130
    [Abstract] [Full Text] [Related]

  • 27. Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas.
    Ni X, Zhang C, Talpur R, Duvic M.
    J Invest Dermatol; 2005 Apr 15; 124(4):741-50. PubMed ID: 15816832
    [Abstract] [Full Text] [Related]

  • 28. Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages.
    Halaas O, Vik R, Ashkenazi A, Espevik T.
    Scand J Immunol; 2000 Mar 15; 51(3):244-50. PubMed ID: 10736093
    [Abstract] [Full Text] [Related]

  • 29. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
    Kaser A, Nagata S, Tilg H.
    Cytokine; 1999 Oct 15; 11(10):736-43. PubMed ID: 10525311
    [Abstract] [Full Text] [Related]

  • 30. Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells.
    De Miguel D, Gallego-Lleyda A, Galan-Malo P, Rodriguez-Vigil C, Marzo I, Anel A, Martinez-Lostao L.
    Clin Transl Oncol; 2015 Aug 15; 17(8):657-67. PubMed ID: 25967100
    [Abstract] [Full Text] [Related]

  • 31. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
    Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H.
    J Immunol; 1999 Aug 15; 163(4):1906-13. PubMed ID: 10438925
    [Abstract] [Full Text] [Related]

  • 32. Actinobacillus actinomycetemcomitans induces apoptosis of T lymphocytes by the Fas and Fas ligand pathway.
    Nalbant A, Zadeh HH.
    Oral Microbiol Immunol; 2002 Oct 15; 17(5):277-84. PubMed ID: 12354208
    [Abstract] [Full Text] [Related]

  • 33. Surfactant protein D delays Fas- and TRAIL-mediated extrinsic pathway of apoptosis in T cells.
    Djiadeu P, Kotra LP, Sweezey N, Palaniyar N.
    Apoptosis; 2017 May 15; 22(5):730-740. PubMed ID: 28168327
    [Abstract] [Full Text] [Related]

  • 34. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R, Bedi A.
    Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014
    [Abstract] [Full Text] [Related]

  • 35. Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome.
    Ishimaru N, Yanagi K, Ogawa K, Suda T, Saito I, Hayashi Y.
    J Immunol; 2001 Nov 15; 167(10):6031-7. PubMed ID: 11698484
    [Abstract] [Full Text] [Related]

  • 36. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL.
    Clin Cancer Res; 2005 Feb 01; 11(3):1010-20. PubMed ID: 15709166
    [Abstract] [Full Text] [Related]

  • 37. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA.
    Cancer Res; 2006 Jun 01; 66(11):5867-74. PubMed ID: 16740726
    [Abstract] [Full Text] [Related]

  • 38. Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL.
    Martínez-Lorenzo MJ, Anel A, Saez-Gutierrez B, Royo-Cañas M, Bosque A, Alava MA, Piñeiro A, Lasierra P, Asín-Ungría J, Larrad L.
    Clin Immunol; 2007 Jan 01; 122(1):28-40. PubMed ID: 16982214
    [Abstract] [Full Text] [Related]

  • 39. Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells.
    Chwae YJ, Chang MJ, Park SM, Yoon H, Park HJ, Kim SJ, Kim J.
    J Immunol; 2002 Oct 01; 169(7):3726-35. PubMed ID: 12244166
    [Abstract] [Full Text] [Related]

  • 40. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF, Erff M, Ashkenazi A.
    Clin Cancer Res; 2001 May 01; 7(5):1362-9. PubMed ID: 11350907
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.